6th May 2021
Deaf Awareness Image

Deafness: Turning a ‘disability’ into an ‘ability’ in the workplace

When our Diversity and Inclusion Ambassadors asked me to write a blog for Deaf Awareness Week, my first thought was ‘Wow! This is the first time, ever, anyone has asked me to write about deafness but, where should I start?’ There is so much I want to say. So, I […]
26th February 2021
Rare Disease Day Logo

Rare diseases and connecting the three Ps: patients, physicians and pharma

By Jayne Carey-George 28th February 2021 is Rare Disease Day®, an important milestone in Sciterion’s calendar, when we take the time to celebrate and raise awareness of the patients, families and carers affected by rare diseases. Let’s take a minute to imagine experiencing tremendous pain every time you walk a […]
20th June 2019

Patient advisory boards in rare diseases: 5 considerations for clinical development

What insights can patients provide? Thanks to technological advances, the ways in which patients are interacting with healthcare organizations are changing. Patients have access to more healthcare information than they’ve ever had, closing the knowledge gap between physicians and patients. Increasingly, patients are making independent decisions on their care or […]
17th March 2019

Grit – a new measure of success

For years we have been measuring and comparing individual’s intelligence quotient (IQ) to assess how smart they are. We have assumed that the higher this is, the more successful someone will be. Indeed this measure has been used to place students into schools, assess intellectual disability and filter job applicants. […]
19th October 2015

Sciterion wins 2015 Communique Award for excellence in meetings

Medical meetings on a global or even European stage raise complex challenges at the best of times. When the objective of the meetings is to raise awareness of and encourage collaboration in a little-known condition across multiple countries with very different clinical approaches, the challenge is even more daunting. Finally, […]
19th October 2015

Medical Affairs key to rapid medicines adoption

Due to rigorous regulatory demands and the need for many years of safety and efficacy research, most medicines only have commercial patent protected lifespans of 10-12 years. This means that the speed of medicines adoption, following regulatory approval, is vitally important to pharmaceutical companies. While there are many factors that […]